Sei Investments Co. Has $20.37 Million Stake in Encompass Health Co. (NYSE:EHC)

Sei Investments Co. cut its stake in Encompass Health Co. (NYSE:EHC) by 3.0% in the fourth quarter, Holdings Channel.com reports. The firm owned 220,599 shares of the company’s stock after selling 6,723 shares during the quarter. Sei Investments Co.’s holdings in Encompass Health were worth $20,373,000 as of its most recent SEC filing.

A number of other large investors have also recently added to or reduced their stakes in the company. MassMutual Private Wealth & Trust FSB boosted its position in shares of Encompass Health by 87.8% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 293 shares of the company’s stock worth $27,000 after buying an additional 137 shares during the period. CBIZ Investment Advisory Services LLC lifted its stake in Encompass Health by 38.7% in the 4th quarter. CBIZ Investment Advisory Services LLC now owns 455 shares of the company’s stock valued at $42,000 after acquiring an additional 127 shares in the last quarter. Tompkins Financial Corp acquired a new position in Encompass Health during the 4th quarter worth approximately $46,000. V Square Quantitative Management LLC grew its stake in shares of Encompass Health by 43.8% during the 4th quarter. V Square Quantitative Management LLC now owns 581 shares of the company’s stock worth $54,000 after acquiring an additional 177 shares in the last quarter. Finally, Signaturefd LLC raised its holdings in shares of Encompass Health by 21.6% in the fourth quarter. Signaturefd LLC now owns 704 shares of the company’s stock valued at $65,000 after purchasing an additional 125 shares during the last quarter. Institutional investors own 97.25% of the company’s stock.

Insider Transactions at Encompass Health

In other Encompass Health news, CAO Andrew L. Price sold 5,042 shares of Encompass Health stock in a transaction dated Thursday, February 13th. The shares were sold at an average price of $98.29, for a total value of $495,578.18. Following the completion of the sale, the chief accounting officer now owns 69,164 shares in the company, valued at $6,798,129.56. The trade was a 6.79 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Insiders own 2.10% of the company’s stock.

Analysts Set New Price Targets

A number of research analysts recently weighed in on the stock. Royal Bank of Canada reaffirmed an “outperform” rating and issued a $110.00 target price on shares of Encompass Health in a research report on Tuesday, February 11th. Barclays lifted their target price on Encompass Health from $116.00 to $118.00 and gave the company an “overweight” rating in a research report on Friday, February 7th. KeyCorp increased their price target on Encompass Health from $117.00 to $120.00 and gave the company an “overweight” rating in a research report on Monday, February 10th. StockNews.com raised Encompass Health from a “hold” rating to a “buy” rating in a research report on Saturday, February 15th. Finally, William Blair reissued an “outperform” rating on shares of Encompass Health in a report on Friday, February 7th. Ten analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat.com, the stock has a consensus rating of “Buy” and a consensus price target of $107.67.

Encompass Health Trading Up 0.8 %

EHC stock opened at $101.19 on Friday. The stock has a market cap of $10.19 billion, a price-to-earnings ratio of 22.69, a price-to-earnings-growth ratio of 2.31 and a beta of 0.92. The company has a fifty day moving average price of $98.55 and a two-hundred day moving average price of $97.31. Encompass Health Co. has a one year low of $78.53 and a one year high of $104.55. The company has a debt-to-equity ratio of 0.84, a current ratio of 1.05 and a quick ratio of 1.04.

Encompass Health (NYSE:EHC) last announced its quarterly earnings results on Thursday, February 6th. The company reported $1.17 EPS for the quarter, beating analysts’ consensus estimates of $1.05 by $0.12. Encompass Health had a net margin of 8.48% and a return on equity of 17.56%. Equities analysts anticipate that Encompass Health Co. will post 4.8 EPS for the current year.

Encompass Health Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, April 15th. Shareholders of record on Tuesday, April 1st will be issued a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 0.67%. The ex-dividend date of this dividend is Tuesday, April 1st. Encompass Health’s dividend payout ratio is 15.25%.

Encompass Health Profile

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.